North America Intravenous (IV) Therapy and Vein Access Market Size, 2028

North America Intravenous (IV) Therapy and Vein Access Market Size, Share & Industry Trends Analysis Report By End User (Hospitals, Ambulatory Surgical Center, and Clinics), By Application, By Type, By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 84 | Format: PDF | Report ID: KBV-17809

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Intravenous (IV) Therapy and Vein Access Market, by End User
1.4.2 North America Intravenous (IV) Therapy and Vein Access Market, by Application
1.4.3 North America Intravenous (IV) Therapy and Vein Access Market, by Type
1.4.4 North America Intravenous (IV) Therapy and Vein Access Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Intravenous (IV) Therapy and Vein Access Market

Chapter 4. North America Intravenous (IV) Therapy and Vein Access Market by End User
4.1 North America Hospitals Market by Country
4.2 North America Ambulatory Surgical Center Market by Country
4.3 North America Clinics Market by Country

Chapter 5. North America Intravenous (IV) Therapy and Vein Access Market by Application
5.1 North America Medication Administration Market by Country
5.2 North America Blood Based Products Market by Country
5.3 North America Nutrition & Buffer Solution Market by Country
5.4 North America Others Market by Country

Chapter 6. North America Intravenous (IV) Therapy and Vein Access Market by Type
6.1 North America Intravenous Catheters Market by Country
6.2 North America Infusion Pumps Market by Country
6.3 North America Hypodermic Needles Market by Country
6.4 North America Implantable Ports Market by Country
6.5 North America Others Market by Country

Chapter 7. North America Intravenous (IV) Therapy and Vein Access Market by Country
7.1 US Intravenous (IV) Therapy and Vein Access Market
7.1.1 US Intravenous (IV) Therapy and Vein Access Market by End User
7.1.2 US Intravenous (IV) Therapy and Vein Access Market by Application
7.1.3 US Intravenous (IV) Therapy and Vein Access Market by Type
7.2 Canada Intravenous (IV) Therapy and Vein Access Market
7.2.1 Canada Intravenous (IV) Therapy and Vein Access Market by End User
7.2.2 Canada Intravenous (IV) Therapy and Vein Access Market by Application
7.2.3 Canada Intravenous (IV) Therapy and Vein Access Market by Type
7.3 Mexico Intravenous (IV) Therapy and Vein Access Market
7.3.1 Mexico Intravenous (IV) Therapy and Vein Access Market by End User
7.3.2 Mexico Intravenous (IV) Therapy and Vein Access Market by Application
7.3.3 Mexico Intravenous (IV) Therapy and Vein Access Market by Type
7.4 Rest of North America Intravenous (IV) Therapy and Vein Access Market
7.4.1 Rest of North America Intravenous (IV) Therapy and Vein Access Market by End User
7.4.2 Rest of North America Intravenous (IV) Therapy and Vein Access Market by Application
7.4.3 Rest of North America Intravenous (IV) Therapy and Vein Access Market by Type

Chapter 8. Company Profiles
8.1 B. Braun Melsungen AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent Strategies and Developments
8.1.5.1 Product launches and Product Expansions:
8.2 Medtronic PLC
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.4 Fresenius SE & Co. KGaA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent Strategies and Developments
8.4.5.1 Acquisitions and Mergers:
8.5 Cardinal Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.6 Pfizer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expense
8.7 Teleflex, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Baxter International, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent Strategies and Developments
8.8.5.1 Approvals and Trials:
8.8.5.2 Acquisitions and Mergers:
8.9 Smiths Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent Strategies and Developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. AngioDynamics, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities